Cargando…

Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach()

Detalles Bibliográficos
Autores principales:	Lamas-Barreiro, José María, Alonso-Suárez, Mario, Fernández-Martín, Jorge Julián, Saavedra-Alonso, Jesus Angel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323640/ http://dx.doi.org/10.1016/j.nefroe.2020.06.014

Ejemplares similares

Supresión de angiotensina II en la infección por el virus SARS-CoV-2: una propuesta terapéutica
por: Lamas-Barreiro, José María, et al.
Publicado: (2020)

The prognostic importance of the angiotensin II/angiotensin-(1–7) ratio in patients with SARS-CoV-2 infection
por: Amezcua-Guerra, Luis M, et al.
Publicado: (2022)

Does Angiotensin II Peak in Response to SARS-CoV-2?
por: Xavier, Léder Leal, et al.
Publicado: (2021)

440 Role of angiotensin II in SARS-CoV-2 pathophysiology in a hamster model of COVID-19
por: Stanic, Branka Milicic, et al.
Publicado: (2023)

Angiotensin‐Converting Enzyme 2 (SARS‐CoV‐2 receptor) expression in human skeletal muscle
por: Perez‐Valera, Mario, et al.
Publicado: (2021)

SARS-CoV-2 infection induces cross-reactive autoantibodies against angiotensin II
por: Briquez, Priscilla S., et al.
Publicado: (2021)

Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
por: Jiang, Yonghou, et al.
Publicado: (2021)

The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

Functional and druggability analysis of the SARS-CoV-2 proteome
por: Cavasotto, Claudio N., et al.
Publicado: (2021)

Linking ACE2 and angiotensin II to pulmonary immunovascular dysregulation in SARS-CoV-2 infection
por: Seltzer, S.
Publicado: (2020)

New Short RNA Motifs Potentially Relevant in the SARS-CoV-2 Genome
por: Fuertes, Miguel Angel, et al.
Publicado: (2023)

Correction to: The renin‑angiotensin system and specifically angiotensin‑converting enzyme 2 as a potential therapeutic target in SARS‑CoV‑2 infections
por: Ferrara, Francesco, et al.
Publicado: (2021)

A REMARKABLE RESPONSE TO ANGIOTENSIN II THERAPY IN SEVERE SARS-COV-2 INFECTION
por: Goetz, Ryan, et al.
Publicado: (2020)

Angiotensin II - A Brief Review and Role in Severe SARS-COV-2 Sepsis
por: Carà, Gianmarco A., et al.
Publicado: (2022)

Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2
por: Sharma, Divakar, et al.
Publicado: (2021)

SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis
por: Delpino, M. Victoria, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting
por: Sharifkashani, Sourena, et al.
Publicado: (2020)

Potential therapeutic approaches for the early entry of SARS-CoV-2 by interrupting the interaction between the spike protein on SARS-CoV-2 and angiotensin-converting enzyme 2 (ACE2)
por: Xiang, Yusen, et al.
Publicado: (2021)

Breast infarction caused by active SARS-CoV-2 infection
por: Vargas Pierola, Harold Jaime, et al.
Publicado: (2022)

HMG Proteins from Molecules to Disease
por: Barreiro-Alonso, Aída, et al.
Publicado: (2022)

Angiotensin II Promotes SARS-CoV-2 Infection via Upregulation of ACE2 in Human Bronchial Cells
por: Caputo, Ilaria, et al.
Publicado: (2022)

Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19
por: Almutlaq, Moudhi, et al.
Publicado: (2022)

Cilostazol suppresses angiotensin II-induced apoptosis in endothelial cells
por: SHI, MIAO-QIAN, et al.
Publicado: (2016)

Herpud1 suppress angiotensin II induced hypertrophy in cardiomyocytes
por: Mikawa, Mei, et al.
Publicado: (2022)

Inhibitors of the renin–angiotensin system and SARS-CoV-2 infection
por: Kessler, Thorsten, et al.
Publicado: (2020)

Drugs acting on the renin–angiotensin system and SARS-CoV-2
por: Vitiello, Antonio, et al.
Publicado: (2021)

Diabetes mellitus and SARS-CoV-2 infection()
por: Alonso, Núria, et al.
Publicado: (2021)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2016)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2020)

Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection
por: Maiti, Biplab K.
Publicado: (2021)

Dysregulation of the Renin-Angiotensin-Aldosterone System (RAA) in Patients Infected with SARS-CoV-2-Possible Clinical Consequences
por: Dettlaff-Pokora, Agnieszka, et al.
Publicado: (2021)

SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients
por: Quarleri, Jorge, et al.
Publicado: (2022)

ACE2 internalization induced by a SARS-CoV-2 recombinant protein is modulated by angiotensin II type 1 and bradykinin 2 receptors
por: Portales, Andrea Estefanía, et al.
Publicado: (2022)

Non-immune Prophylaxis Against COVID-19 by Targeting Tolerance for Angiotensin II-Triggered SARS-CoV-2 Pathogenesis
por: Dubina, Michael V.
Publicado: (2022)

Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells
por: Okoloko, Oghenemega, et al.
Publicado: (2021)

Vulnerability to SARS-CoV-2 infection and disease: ripping the curl after the storm
por: Barreiro, Pablo, et al.
Publicado: (2022)

Influence of aging on T cell response and renin-angiotensin system imbalance during SARS-CoV-2 infection
por: Quarleri, Jorge, et al.
Publicado: (2021)

Angiotensin II: a new therapeutic option for vasodilatory shock
por: Bussard, Rachel L, et al.
Publicado: (2018)

Angiotensin II-derived constrained peptides with antiplasmodial activity and suppressed vasoconstriction
por: Silva, Adriana Farias, et al.
Publicado: (2017)

Paeonol improves angiotensin II-induced cardiac hypertrophy by suppressing ferroptosis
por: Liu, Canzhang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6u9pj3kfubjdafbe8jq8istdns